BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16796173)

  • 1. [Tiotropium, a long-acting bronchodilating agent for the treatment of COPD].
    Schuurbiers OC; Schermer TR; Dekhuijzen PN; van Weel C
    Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1227-32. PubMed ID: 16796173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
    Somand H; Remington TL
    Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM; Welte T; Buhl R
    Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
    Koumis T; Samuel S
    Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tiotropium: a new therapeutic option in chronic obstructive pulmonary disease].
    Corhay JL; Louis R
    Rev Med Suisse; 2005 Aug; 1(30):1967-9, 1971-2. PubMed ID: 16200941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN; Broeders ME; Tuut MK; Grol MH
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1465-8. PubMed ID: 18666664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
    Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
    Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator].
    Izquierdo Alonso JL
    An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tiotropium as new quality medication in the COPD management].
    Lubiński W; Płusa T
    Pol Merkur Lekarski; 2006 Jan; 20(115):5-7. PubMed ID: 16617725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiotropium bromide: a long-acting anticholinergic bronchodilator for the treatment of patients with chronic obstructive pulmonary disease.
    Joos GF; Brusselle G; Derom E; Pauwels R
    Int J Clin Pract; 2003 Dec; 57(10):906-9. PubMed ID: 14712894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study.
    Incorvaia C; Riario-Sforza GG; Pravettoni C; Dugnani N; Paterniti F; Pessina L; Fumagalli M
    Respir Med; 2007 Mar; 101(3):476-80. PubMed ID: 16919926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The verge and the abyss: tiotropium (Spiriva) in COPD].
    Segel MJ; Ben-Dov I
    Harefuah; 2011 Jan; 150(1):61-3, 66. PubMed ID: 21449160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium: a new, long-acting agent for the management of COPD--a clinical review.
    Crutchfield D
    Director; 2004; 12(3):160, 162-4. PubMed ID: 15323298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected? Evaluation of Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(10): 948-55.
    Sampablo I; Carone M; Antoniu SA
    Expert Opin Pharmacother; 2010 Jun; 11(8):1439-41. PubMed ID: 20446856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
    Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
    Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
    Niewoehner DE
    Am J Med; 2006 Oct; 119(10 Suppl 1):38-45. PubMed ID: 16996898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.